Term infant formula supplemented with milk-derived oligosaccharides shifts the gut microbiota closer to that of human milk-fed infants and improves intestinal immune defense: a randomized controlled trial
Elvira Estorninos, Rachel Lawenko, Eisel Palestroque, Norbert Sprenger, Jalil Benyacoub, Guus A. M. Kortman +4 more
American Journal of Clinical Nutrition
Abstract
Infant formula with MOS shifts the gut microbiota and metabolic signature closer to that of HFI, has a strong bifidogenic effect, reduces fecal pathogens, and improves the intestinal immune response.
Extracted Claims
4 claims extracted from this paper into the knowledge graph
infant formula with milk-derived oligosaccharides (MOS) has strong bifidogenic effect
“Infant formula with MOS shifts the gut microbiota and metabolic signature closer to that of HFI, has a strong bifidogenic effect, reduces fecal pathogens, and improves the intestinal immune response.”
infant formula with milk-derived oligosaccharides (MOS) improves intestinal immune response
“Infant formula with MOS shifts the gut microbiota and metabolic signature closer to that of HFI, has a strong bifidogenic effect, reduces fecal pathogens, and improves the intestinal immune response.”
infant formula with milk-derived oligosaccharides (MOS) reduces fecal pathogens
“Infant formula with MOS shifts the gut microbiota and metabolic signature closer to that of HFI, has a strong bifidogenic effect, reduces fecal pathogens, and improves the intestinal immune response.”